To test the impact of USP5 on antitumor immunity, we performed IHC staining of USP5 protein and multiplex immunofluorescent staining of CD68+, CXCL9+, CD8+, and GZMB+ cells in 31 NPC tissues. The gene discussed is USP5; the disease is nasopharyngeal carcinoma.